Dwight Stoll received an Agilent Technologies Foundation grant for the study of two-dimensional liquid chromatography separations of therapeutic monoclonal antibodies.
Dwight Stoll received an Agilent Technologies Foundation grant for the study of two-dimensional liquid chromatography separations of therapeutic monoclonal antibodies.